查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蛋白質表達市場：市場規模、份額、趨勢分析、機會、預測——按系統類型、應用、最終用戶、地區劃分 (2019-2029)
市場調查報告書
商品編碼
1227606

全球蛋白質表達市場：市場規模、份額、趨勢分析、機會、預測——按系統類型、應用、最終用戶、地區劃分 (2019-2029)

Protein Expression Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2029, Segmented By System Type ; By Application ; By End User ; By Region
出版日期: | 出版商: Blueweave Consulting | 英文 400 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球蛋白表達市場規模將在 2022 年達到 31.2 億美元，到 2029 年達到 71.6 億美元，在 2023-2029 年的預測期內以 12.63% 的複合年增長率增長。

由於生物製藥公司增加了對蛋白質表達研發的投資以及越來越多地採用基於重組的蛋白質表達，因此全球市場正在蓬勃發展。

本報告考察了全球蛋白表達市場，並提供了市場洞察、市場概況、區域市場分析、競爭格局、公司概況等資訊。

內容

第 1 章研究框架

第 2 章執行摘要

第 3 章全球蛋白質表達市場洞察

  • 工業價值鏈分析
  • DROC 分析
    • 促進因素
      • 對蛋白質生物製劑的需求增加
      • 增加製藥和生物製藥行業的研發
      • 越來越多地採用基於重組的蛋白質表達
      • 蛋白質研究的資金可用性
    • 抑制因素
      • 蛋白表達試劑和設備成本高
      • 整合程度提高，新進入者門檻高
    • 機會
      • 微流體的出現
      • 具有巨大增長潛力的新興經濟體
    • 任務
      • 不良的翻譯後修飾和純化
  • 技術進步/最新發展
  • 監管框架
  • 波特的五力分析
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭激烈程度

第 4 章全球蛋白表達市場概述

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
      • 哺乳動物細胞表達系統
      • 原核表達系統
      • 昆蟲細胞表達系統
      • 酵母表達系統
      • 無細胞表達系統
      • 基於藻類的表達系統
    • 按使用
      • 治療
      • 研究
      • 工業
    • 最終用戶
      • 製藥和生物技術公司
      • 承包研究機構/承包開發和製造組織 (CROS/CDMOS)
      • 學術研究所
      • 其他
    • 按地區
      • 北美
      • 歐洲
      • 亞太地區
      • 拉丁美洲
      • 中東和非洲

第 5 章北美蛋白表達市場

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
    • 按使用
    • 最終用戶
    • 按國家
      • 美國
      • 加拿大

第 6 章歐洲蛋白表達市場

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
    • 按使用
    • 最終用戶
    • 按國家
      • 德國
      • 英國
      • 意大利
      • 法國
      • 西班牙
      • 荷蘭
      • 其他歐洲

第 7 章亞太蛋白表達市場

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
    • 按使用
    • 最終用戶
    • 按國家
      • 中國
      • 印度
      • 日本
      • 韓國
      • 澳大利亞和新西蘭
      • 印度尼西亞
      • 馬來西亞
      • 新加坡
      • 菲律賓
      • 越南
      • 亞太其他地區

第 8 章拉丁美洲的蛋白質表達市場

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
    • 按使用
    • 最終用戶
    • 按國家
      • 巴西
      • 墨西哥
      • 阿根廷
      • 秘魯
      • 哥倫比亞
      • 其他拉丁美洲

第 9 章中東和非洲的蛋白質表達市場

  • 2019-2029 年市場規模和預測
    • 按金額（十億美元）
  • 市場份額/預測
    • 按系統類型
    • 按使用
    • 最終用戶
    • 按國家
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國
      • 卡塔爾
      • 科威特
      • 南非
      • 尼日利亞
      • 阿爾及利亞
      • 其他中東和非洲地區

第10章競爭格局

  • 主要公司和產品列表
  • 2022 年全球蛋白表達公司市場份額分析
  • 競爭基準：按運營參數
  • 重大戰略發展（合併、收購、合作等）

第 11 章 COVID-19 對全球蛋白表達市場的影響

第 12 章公司概況（公司概況、財務矩陣、競爭格局、主要人員、主要競爭對手、聯繫地址、戰略前景、SWOT分析）

  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • GenScript Biotech Corporation
  • Agilent Technologies, Inc.
  • Takara Bio, Inc.
  • Bio-Rad Laboratories, Inc
  • Qiagen N.V
  • Charles River Laboratories, Inc.
  • Danaher Corporation
  • Sartorius AG
  • Corning Incorporated
  • FUJIFILM Irvine Scientific, Inc.
  • Lonza Group AG
  • Bioneer Corporation
  • Promega Corporation
  • Oxford Expression Technologies Ltd
  • 其他有影響力的公司

第 13 章關鍵戰略建議

第 14 章研究方法論

簡介目錄
Product Code: BWC23135

Global Protein Expression Market Size More Than Doubles to Reach USD 7.2 Billion by 2029.

The global protein expression market is gaining traction because of the increasing investments in R&D protein expression by biopharmaceutical companies and growing adoption of recombinant-based protein expression.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the global protein expression market size at USD 3.12 billion in 2022. During the forecast period between 2023 and 2029, the global protein expression market size is projected to grow at an impressive CAGR of 12.63% reaching a value of USD 7.16 billion by 2029. The growing use of protein expression in the biopharmaceutical and life sciences sector for the development of novel medications and treatments is one of the major growth reasons for the global protein expression market. Protein expression is the subject of intensive research and development efforts as a result of the rising incidence of cancer and other chronic diseases throughout the world, which is fueling the market's expansion.

Global Protein Expression Market - Overview:

The process through which proteins are created, altered, and controlled in living organisms is referred to as protein expression. The analysis of protein expression in cancer cells may provide details about a particular type of cancer, the optimal course of treatment, and the effectiveness of a particular course of treatment. For further studies, such as identifying the three-dimensional structure of proteins, as chemical instruments or probes, or as novel classes of pharmaceuticals, among others, expressed protein products that are functional and exhibit traits comparable to their native counterparts are helpful.

Global Protein Expression Market - By End User:

Based on end users, the global protein expression market is segmented into pharmaceutical and biotechnology companies, contract research organizations and contract development and manufacturing organizations (CROs and CDMOs), academic research institutes, and others. The pharmaceutical and biotechnology company segment accounts for the highest market share. Protein expression is widely used in pharmaceutical and biotechnology companies to carry out research and develop new drugs. CROs are also gaining traction owing to increasing outsourcing of research activities at lower costs which helps companies increase their profit margins.

Impact of COVID-19 on Global Protein Expression Market

The unprecedented COVID-19 pandemic outbreak brought various growth opportunities for the global protein expression market. According to earlier research, the novel coronavirus infects people via infecting epithelial cells by connecting with the human ACE2 receptor protein on their surface. As a result, extensive research activities surrounding the study of the protein expression status of angiotensin-converting enzyme 2 (ACE2) to understand the hypothesized correlation of the level of ACE2 expression in lungs with an increased risk of severe infection and complications in COrona VIrus Disease 2019 (COVID-19). Several other types of research like these with the application of protein expression also played a crucial role in tackling the COVID-19 pandemic.

Competitive Landscape:

Major players operating in the global Protein Expression market include: Thermo Fisher Scientific, Inc., Merck KGaA, GenScript Biotech Corporation, Agilent Technologies, Inc., Takara Bio, Inc., Bio-Rad Laboratories, Inc, Qiagen N.V, Charles River Laboratories, Inc., Danaher Corporation, Sartorius AG, Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Lonza Group AG, Bioneer Corporation, Promega Corporation, and Oxford Expression Technologies Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Protein Expression Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Protein Expression Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Protein Expression Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Protein Expression Market Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Increasing demand for protein biologics
      • 3.2.1.2. Increasing R&D in pharmaceutical and biopharmaceutical industries
      • 3.2.1.3. Growing adoption of recombinant-based protein expression
      • 3.2.1.4. Availability of funding for protein-based research
    • 3.2.2. Restraints
      • 3.2.2.1. High cost of protein expression reagents and instruments
      • 3.2.2.2. Increasing consolidation and high barriers for new entrants
    • 3.2.3. Opportunities
      • 3.2.3.1. Emergence of microfluidics
      • 3.2.3.2. Emerging economies offering significant growth potential
    • 3.2.4. Challenges
      • 3.2.4.1. Undesired post-translational modifications and purification
  • 3.3. Technology Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Protein Expression Market Overview

  • 4.1. Market Size & Forecast by Value, 2019-2029
    • 4.1.1. By Value (USD Billion)
  • 4.2. Market Share & Forecast
    • 4.2.1. By System Type
      • 4.2.1.1. Mammalian Cell Expression Systems
      • 4.2.1.2. Prokaryotic expression systems
      • 4.2.1.3. Insect cell expression systems
      • 4.2.1.4. Yeast expression systems
      • 4.2.1.5. Cell-free expression systems
      • 4.2.1.6. Algal-based expression systems
    • 4.2.2. By Application
      • 4.2.2.1. Therapeutic
      • 4.2.2.2. Research
      • 4.2.2.3. Industrial
    • 4.2.3. By End User
      • 4.2.3.1. Pharmaceutical and Biotechnology companies
      • 4.2.3.2. Contract Research Organizations and Contract Development and Manufacturing Organizations (CROS and CDMOS)
      • 4.2.3.3. Academic Research Institutes
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia Pacific (APAC)
      • 4.2.4.4. Latin America (LATAM)
      • 4.2.4.5. Middle East and Africa (MEA)

5. North America Protein Expression Market

  • 5.1. Market Size & Forecast by Value, 2019-2029
    • 5.1.1. By Value (USD Billion)
  • 5.2. Market Share & Forecast
    • 5.2.1. By System Type
    • 5.2.2. By Application
    • 5.2.3. By End User
    • 5.2.4. By Country
      • 5.2.4.1. US
      • 5.2.4.1.1. By System Type
      • 5.2.4.1.2. By Application
      • 5.2.4.1.3. By End User
      • 5.2.4.2. Canada
      • 5.2.4.2.1. By System Type
      • 5.2.4.2.2. By Application
      • 5.2.4.2.3. By End User

6. Europe Protein Expression Market

  • 6.1. Market Size & Forecast by Value, 2019-2029
    • 6.1.1. By Value (USD Billion)
  • 6.2. Market Share & Forecast
    • 6.2.1. By System Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
      • 6.2.4.1. Germany
      • 6.2.4.1.1. By System Type
      • 6.2.4.1.2. By Application
      • 6.2.4.1.3. By End User
      • 6.2.4.2. UK
      • 6.2.4.2.1. By System Type
      • 6.2.4.2.2. By Application
      • 6.2.4.2.3. By End User
      • 6.2.4.3. Italy
      • 6.2.4.3.1. By System Type
      • 6.2.4.3.2. By Application
      • 6.2.4.3.3. By End User
      • 6.2.4.4. France
      • 6.2.4.4.1. By System Type
      • 6.2.4.4.2. By Application
      • 6.2.4.4.3. By End User
      • 6.2.4.5. Spain
      • 6.2.4.5.1. By System Type
      • 6.2.4.5.2. By Application
      • 6.2.4.5.3. By End User
      • 6.2.4.6. The Netherlands
      • 6.2.4.6.1. By System Type
      • 6.2.4.6.2. By Application
      • 6.2.4.6.3. By End User
      • 6.2.4.7. Rest of Europe
      • 6.2.4.7.1. By System Type
      • 6.2.4.7.2. By Application
      • 6.2.4.7.3. By End User

7. Asia Pacific Protein Expression Market

  • 7.1. Market Size & Forecast by Value, 2019-2029
    • 7.1.1. By Value (USD Billion)
  • 7.2. Market Share & Forecast
    • 7.2.1. By System Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
      • 7.2.4.1. China
      • 7.2.4.1.1. By System Type
      • 7.2.4.1.2. By Application
      • 7.2.4.1.3. By End User
      • 7.2.4.2. India
      • 7.2.4.2.1. By System Type
      • 7.2.4.2.2. By Application
      • 7.2.4.2.3. By End User
      • 7.2.4.3. Japan
      • 7.2.4.3.1. By System Type
      • 7.2.4.3.2. By Application
      • 7.2.4.3.3. By End User
      • 7.2.4.4. South Korea
      • 7.2.4.4.1. By System Type
      • 7.2.4.4.2. By Application
      • 7.2.4.4.3. By End User
      • 7.2.4.5. Australia & New Zealand
      • 7.2.4.5.1. By System Type
      • 7.2.4.5.2. By Application
      • 7.2.4.5.3. By End User
      • 7.2.4.6. Indonesia
      • 7.2.4.6.1. By System Type
      • 7.2.4.6.2. By Application
      • 7.2.4.6.3. By End User
      • 7.2.4.7. Malaysia
      • 7.2.4.7.1. By System Type
      • 7.2.4.7.2. By Application
      • 7.2.4.7.3. By End User
      • 7.2.4.8. Singapore
      • 7.2.4.8.1. By System Type
      • 7.2.4.8.2. By Application
      • 7.2.4.8.3. By End User
      • 7.2.4.9. Philippines
      • 7.2.4.9.1. By System Type
      • 7.2.4.9.2. By Application
      • 7.2.4.9.3. By End User
      • 7.2.4.10. Vietnam
      • 7.2.4.10.1. By System Type
      • 7.2.4.10.2. By Application
      • 7.2.4.10.3. By End User
      • 7.2.4.11. Rest of APAC
      • 7.2.4.11.1. By System Type
      • 7.2.4.11.2. By Application
      • 7.2.4.11.3. By End User

8. Latin America Protein Expression Market

  • 8.1. Market Size & Forecast by Value, 2019-2029
    • 8.1.1. By Value (USD Billion)
  • 8.2. Market Share & Forecast
    • 8.2.1. By System Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
      • 8.2.4.1. Brazil
      • 8.2.4.1.1. By System Type
      • 8.2.4.1.2. By Application
      • 8.2.4.1.3. By End User
      • 8.2.4.2. Mexico
      • 8.2.4.2.1. By System Type
      • 8.2.4.2.2. By Application
      • 8.2.4.2.3. By End User
      • 8.2.4.3. Argentina
      • 8.2.4.3.1. By System Type
      • 8.2.4.3.2. By Application
      • 8.2.4.3.3. By End User
      • 8.2.4.4. Peru
      • 8.2.4.4.1. By System Type
      • 8.2.4.4.2. By Application
      • 8.2.4.4.3. By End User
      • 8.2.4.5. Colombia
      • 8.2.4.5.1. By System Type
      • 8.2.4.5.2. By Application
      • 8.2.4.5.3. By End User
      • 8.2.4.6. Rest of LATAM
      • 8.2.4.6.1. By System Type
      • 8.2.4.6.2. By Application
      • 8.2.4.6.3. By End User

9. Middle East & Africa Protein Expression Market

  • 9.1. Market Size & Forecast by Value, 2019-2029
    • 9.1.1. By Value (USD Billion)
  • 9.2. Market Share & Forecast
    • 9.2.1. By System Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
      • 9.2.4.1. Saudi Arabia
      • 9.2.4.1.1. By System Type
      • 9.2.4.1.2. By Application
      • 9.2.4.1.3. By End User
      • 9.2.4.2. UAE
      • 9.2.4.2.1. By System Type
      • 9.2.4.2.2. By Application
      • 9.2.4.2.3. By End User
      • 9.2.4.3. Qatar
      • 9.2.4.3.1. By System Type
      • 9.2.4.3.2. By Application
      • 9.2.4.3.3. By End User
      • 9.2.4.4. Kuwait
      • 9.2.4.4.1. By System Type
      • 9.2.4.4.2. By Application
      • 9.2.4.4.3. By End User
      • 9.2.4.5. South Africa
      • 9.2.4.5.1. By System Type
      • 9.2.4.5.2. By Application
      • 9.2.4.5.3. By End User
      • 9.2.4.6. Nigeria
      • 9.2.4.6.1. By System Type
      • 9.2.4.6.2. By Application
      • 9.2.4.6.3. By End User
      • 9.2.4.7. Algeria
      • 9.2.4.7.1. By System Type
      • 9.2.4.7.2. By Application
      • 9.2.4.7.3. By End User
      • 9.2.4.8. Rest of MEA
      • 9.2.4.8.1. By System Type
      • 9.2.4.8.2. By Application
      • 9.2.4.8.3. By End User

10. Competitive Landscape

  • 10.1. List of Key Players and Their Offerings
  • 10.2. Global Protein Expression Company Market Share Analysis, 2022
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Development (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Protein Expression Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

  • 12.1. Thermo Fisher Scientific, Inc.
  • 12.2. Merck KGaA
  • 12.3. GenScript Biotech Corporation
  • 12.4. Agilent Technologies, Inc.
  • 12.5. Takara Bio, Inc.
  • 12.6. Bio-Rad Laboratories, Inc
  • 12.7. Qiagen N.V
  • 12.8. Charles River Laboratories, Inc.
  • 12.9. Danaher Corporation
  • 12.10. Sartorius AG
  • 12.11. Corning Incorporated
  • 12.12. FUJIFILM Irvine Scientific, Inc.
  • 12.13. Lonza Group AG
  • 12.14. Bioneer Corporation
  • 12.15. Promega Corporation
  • 12.16. Oxford Expression Technologies Ltd
  • 12.17. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research
    • 14.1.1. Primary & Secondary Research
  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumption & Limitation